Suppr超能文献

一氧化氮对2型糖尿病患者皮肤微血管扩张的作用。

Contribution of nitric oxide to cutaneous microvascular dilation in individuals with type 2 diabetes mellitus.

作者信息

Sokolnicki Lynn A, Roberts Shelly K, Wilkins Bradley W, Basu Ananda, Charkoudian Nisha

机构信息

Dept. of Physiology and Biomedical Engineering, JO 4-184W, Mayo Clinic College of Medicine, 200 First St. SW, Rochester, MN 55901, USA.

出版信息

Am J Physiol Endocrinol Metab. 2007 Jan;292(1):E314-8. doi: 10.1152/ajpendo.00365.2006. Epub 2006 Sep 5.

Abstract

Microvascular pathophysiology associated with type 2 diabetes mellitus (T2DM) contributes to several aspects of the morbidity associated with the disease. We quantified the contribution of nitric oxide (NO) to the cutaneous vasodilator response to nonpainful local warming in subjects with T2DM (average duration of diabetes mellitus 7 +/- 1 yr) and in age-matched control subjects. We measured skin blood flow in conjunction with intradermal microdialysis of N(G)-nitro-l-arginine methyl ester (l-NAME; NO synthase inhibitor) or vehicle during 35 min of local warming to 42 degrees C. Microdialysis of sodium nitroprusside (SNP) was used for assessment of maximum cutaneous vascular conductance (CVC). Resting CVC was higher in T2DM subjects at vehicle sites (T2DM: 19 +/- 2 vs. control: 11 +/- 3%maxCVC; P < 0.05); this difference was abolished by l-NAME (T2DM: 10 +/- 1 vs. control: 8 +/- 1%maxCVC; P > 0.05). The relative contribution of NO to the vasodilator response to local warming was not different between groups (T2DM: 46 +/- 4 vs. control: 44 +/- 6%maxCVC; P > 0.05). However, absolute CVC during local warming was approximately 25% lower in T2DM subjects (T2DM: 1.79 +/- 0.15 AU/mmHg; controls: 2.42 +/- 0.20 AU/mmHg; P < 0.01), and absolute CVC during SNP was approximately 20% lower (T2DM: 1.91 +/- 0.12 vs. control: 2.38 +/- 0.13 AU/mmHg; P < 0.01). We conclude that the relative contribution of NO to vasodilation during local warming is similar between subjects with T2DM and control subjects, although T2DM was associated with a lower absolute maximum vasodilation.

摘要

与2型糖尿病(T2DM)相关的微血管病理生理学导致了该疾病发病的多个方面。我们量化了一氧化氮(NO)对T2DM患者(糖尿病平均病程7±1年)和年龄匹配的对照受试者非疼痛性局部升温时皮肤血管舒张反应的贡献。在局部升温至42℃的35分钟内,我们结合皮内微量透析N(G)-硝基-L-精氨酸甲酯(L-NAME;NO合酶抑制剂)或赋形剂测量皮肤血流量。硝普钠(SNP)的微量透析用于评估最大皮肤血管传导率(CVC)。在赋形剂部位,T2DM患者的静息CVC较高(T2DM:19±2 vs.对照:11±3%最大CVC;P<0.05);L-NAME消除了这种差异(T2DM:10±1 vs.对照:8±1%最大CVC;P>0.05)。两组之间,NO对局部升温血管舒张反应的相对贡献没有差异(T2DM:46±4 vs.对照:44±6%最大CVC;P>0.05)。然而,T2DM患者在局部升温期间的绝对CVC约低25%(T2DM:1.79±0.15 AU/mmHg;对照组:2.42±0.20 AU/mmHg;P<0.01),SNP期间的绝对CVC约低20%(T2DM:1.91±0.12 vs.对照:2.38±0.13 AU/mmHg;P<0.01)。我们得出结论,尽管T2DM与较低的绝对最大血管舒张相关,但在局部升温期间,NO对血管舒张的相对贡献在T2DM患者和对照受试者之间相似。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验